Mesoblast (ASX:MSB) Short Ratio


ASX:MSB Mesoblast Ltd ASX:MSB
46 GF Score
Price A$2.06
! 4 Warning Signs
View Full Analysis

What is Mesoblast Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:MSB
46GF Score
Mesoblast Ltd ASX:MSB
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mesoblast Business Description

Address 55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
46GF Score

Get the complete analysis for ASX:MSB

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.06
Price